ScoutQuest2 Nov 2026
Akums Drugs and Pharmaceuticals544222Quarterly results

Board approves unaudited results, designates President – Operations as Senior Management Personnel

Board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026.

By ScoutQuest · · 2 min read

Standalone revenue from operations (Q2)
₹ 3,950.47 million
Standalone profit for the period (Q2)
₹ 326.37 million
Income-tax demand under appeal (standalone)
₹ 600.92 million

Board decisions

Standalone results

For the quarter ended September 30, 2026, Revenue from operations was ₹ 3,950.47 million. Profit for the period was ₹ 326.37 million. Earning per share (basic and diluted) was ₹ 2.13. These are unaudited standalone figures, reviewed by the statutory auditor.

Auditor's review

Walker Chandiok & Co LLP issued limited review reports on the standalone and consolidated results. The conclusion is unmodified. The auditor drew attention to a note on an income-tax search and seizure and an assessment order. For standalone, the tax demand is ₹ 600.92 million for the block period from 01 April 2018 to 12 March 2025. The company has shared an appeal before the Commissioner of Income-tax (Appeals); management believes no adjustment is required; the auditor's conclusion is not modified. For consolidated, the auditor drew attention to a tax demand aggregating ₹ 1,560.18 million for the same block period, with a similar appeal and management view.

Dividend

Shareholders approved a final and special dividend aggregating ₹ 3 per equity share for the financial year ended 31 March 2026. The total dividend liability was ₹ 472.18 million.

What it means for retail investors

The update shows the Board cleared the quarterly accounts and an auditor-reviewed result set, with no modification in the review conclusion. The tax demand is a disclosed dispute, and the company's position is that no adjustment is required. The management designation is an internal organisational change. The IPO proceeds update indicates full utilisation.

More numbers
  • Revenue from operations, standalone Q2 FY27 (₹ million)3,950.47
  • Profit for the period, standalone Q2 FY27 (₹ million)326.37
  • Basic and diluted EPS, standalone Q2 FY27 (₹)2.13
  • Standalone income-tax demand under appeal₹ 600.92 million
  • Consolidated income-tax demand under appeal₹ 1,560.18 million
  • Final plus special dividend per equity share₹ 3 per equity share
  • Total dividend liability₹ 472.18 million
  • IPO proceeds utilisedhundred per cent (100%)
Source: BSE · 2 Nov 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev